177 related articles for article (PubMed ID: 14616965)
1. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
[TBL] [Abstract][Full Text] [Related]
4. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
Okabe-Kado J
Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
[TBL] [Abstract][Full Text] [Related]
5. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
[TBL] [Abstract][Full Text] [Related]
6. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M
Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128
[TBL] [Abstract][Full Text] [Related]
8. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.
Yamaguchi A; Ding K; Maehara M; Goi T; Nakagawara G
Oncology; 1998; 55(4):357-62. PubMed ID: 9663428
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of nm23 protein expression in renal cell carcinomas.
Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
[TBL] [Abstract][Full Text] [Related]
12. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
[TBL] [Abstract][Full Text] [Related]
13. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
Niitsu N
J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
[TBL] [Abstract][Full Text] [Related]
14. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.
Iizuka N; Tangoku A; Hayashi H; Yosino S; Abe T; Morioka T; Oka M
Cancer Lett; 1999 Apr; 138(1-2):139-44. PubMed ID: 10378785
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.
Alvaro-Naranjo T; Lejeune M; Salvadó-Usach MT; Bosch-Príncep R; Reverter-Branchat G; Jaén-Martínez J; Pons-Ferré LE
Leuk Lymphoma; 2005 Nov; 46(11):1581-91. PubMed ID: 16236613
[TBL] [Abstract][Full Text] [Related]
16. The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
Baekelandt M; Holm R; Tropé CG; Nesland JM; Kristensen GB
Ann Oncol; 1999 Nov; 10(11):1335-41. PubMed ID: 10631462
[TBL] [Abstract][Full Text] [Related]
17. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
[TBL] [Abstract][Full Text] [Related]
18. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
[TBL] [Abstract][Full Text] [Related]
19. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
20. [Low expression of nm23-H1 mRNA and its protein in breast cancer].
Guo W; Wang Y; Zhuang X; Bai Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):91-3. PubMed ID: 10751528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
